AI in healthcare is creating opportunities that will result in better affordability, availability, speed & personalization. The pressure on healthcare systems is not just to improve outcomes, but to democratize it, often with limited resources. AI is uniquely positioned here, not as a replacement for clinical expertise, but as an augmentation layer that improves decision-making at every stage. Applying AI in the right places can improve outcomes, reduce costs, and free up clinical capacity where it matters most.
The shift is already underway. According to Statista, over 50% of healthcare organizations are actively investing in AI, and the global AI in healthcare market is expected to grow rapidly in the coming years. At the same time, studies show that AI-enabled interventions can improve diagnostic accuracy by 10–20% in certain conditions, while significantly reducing time to diagnosis.
What matters is where and how AI is applied. At Cortia, the focus is on identifying points in the care and research lifecycle where AI can meaningfully shift outcomes. Some of the areas where AI makes a significant difference are:
This enables earlier and more accurate disease detection by supporting clinicians with pattern recognition and data-driven insights. In areas like radiology and oncology, AI models have demonstrated accuracy rates comparable to or exceeding human experts in specific tasks.
This helps anticipate risks, personalize treatment pathways, and improve patient outcomes through proactive intervention. A study by Deloitte says, hospitals using predictive analytics have reported reductions in readmission rates by up to 15–20% and better resource utilization.
One area where research cycles are accelerated by identifying viable compounds faster and reducing time-to-market. AI has been shown to reduce early-stage drug discovery timelines by up to 30–50%, significantly lowering R&D costs.